Hims & Hers Health Inc. (HIMS)
| Bid | 36.89 |
| Market Cap | 7.91B |
| Revenue (ttm) | 1.44B |
| Net Income (ttm) | 123.02M |
| EPS (ttm) | 0.53 |
| PE Ratio (ttm) | 69.81 |
| Forward PE | 32.18 |
| Analyst | Hold |
| Ask | 36.98 |
| Volume | 15,846,626 |
| Avg. Volume (20D) | 21,875,728 |
| Open | 37.82 |
| Previous Close | 37.41 |
| Day's Range | 35.77 - 38.69 |
| 52-Week Range | 11.20 - 72.98 |
| Beta | 1.37 |
About HIMS
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmeti...
Analyst Forecast
According to 12 analyst ratings, the average rating for HIMS stock is "Hold." The 12-month stock price forecast is $35, which is a decrease of -5.41% from the latest price.
Stock ForecastsNext Earnings Release
Analysts project revenue of ... Unlock content with Pro Subscription
19 hours ago · seekingalpha.com
The Case For Hims & Hers: Diversification And Growth Beyond SemaglutideHims & Hers has risen 70% since November 2024, outperforming the S&P 500, despite recent regulatory challenges impacting its compounded semaglutide product. Its diversified portfolio in men's and wome...
